Singapore markets closed

Coeptis Therapeutics Holdings, Inc. (COEP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2810+0.0010 (+0.36%)
At close: 04:00PM EDT
0.2911 +0.01 (+3.59%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
75
30.761
Cost of revenue
0
0
0
0
964.217
Gross profit
0
0
0
75
-933.456
Operating expenses
Research development
7,330
6,668
20.887
0
3.543
Selling general and administrative
10,545
14,823
34,175
14,121
5,776
Total operating expenses
17,875
21,491
34,196
14,121
5,780
Operating income or loss
-17,875
-21,491
-34,196
-14,046
-6,713
Interest expense
276.773
107.685
218.412
187.133
148.192
Total other income/expenses net
1,841
332.273
-3,160
783.786
-2,295
Income before tax
-16,310
-21,267
-37,574
-13,449
-9,156
Income tax expense
0
0
0
0
0
Income from continuing operations
-16,310
-21,267
-37,574
-13,449
-9,156
Net income
-16,310
-21,267
-37,574
-13,449
-9,156
Net income available to common shareholders
-16,310
-21,267
-37,574
-13,449
-9,156
Basic EPS
-0.61
-
-2.63
-0.66
-0.45
Diluted EPS
-0.61
-
-2.63
-0.66
-0.45
Basic average shares
32,991
-
14,296
20,441
20,441
Diluted average shares
32,991
-
14,296
20,441
20,441